🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
EDI
$EDIT
🔒 US EquitiesEditas Medicine Inc
AVG HISTORICAL GAP
+2.71%
MAX GAP RECORD
+15.58%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $EDIT
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$EDIT
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 05, 2026 Earnings Release 2026-08-05 (AFTER CLOSE) |
+2.55%
|
| May 05, 2026 Earnings Release 2026-05-05 (BEFORE OPEN) |
+0.67%
|
| Mar 09, 2026 Earnings Release 2026-03-09 (BEFORE OPEN) |
-1.00%
|
| Nov 10, 2025 Earnings Release 2025-11-10 (BEFORE OPEN) |
+9.51%
|
| Aug 12, 2025 Earnings Release 2025-08-12 (AFTER CLOSE) |
+6.99%
|
| May 12, 2025 Earnings Release 2025-05-12 (AFTER CLOSE) |
+0.65%
|
| Mar 05, 2025 Earnings Release 2025-03-05 (AFTER CLOSE) |
-5.85%
|
| Nov 04, 2024 Earnings Release 2024-11-04 (BEFORE OPEN) |
-0.34%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.9%
Bullish Gaps (8)
Bearish Gaps (2)
Neutral / Flat (5)
📖 Intelligence Summary
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu on…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗